E
LSL Pharma Group Inc. LSL.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 11.63M 10.56M 9.02M 7.42M 6.57M
Total Other Revenue -- -- -- -- --
Total Revenue 11.63M 10.56M 9.02M 7.42M 6.57M
Cost of Revenue 8.71M 8.17M 7.23M 6.20M 6.33M
Gross Profit 2.92M 2.39M 1.79M 1.22M 237.10K
SG&A Expenses 2.77M 2.49M 2.19M 3.51M 3.90M
Depreciation & Amortization 25.70K 24.60K 24.60K 24.60K 24.60K
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 11.45M 10.63M 9.46M 9.78M 10.58M
Operating Income 182.40K -68.60K -447.90K -2.35M -4.01M
Income Before Tax -1.22M -1.50M -1.90M -5.68M -7.56M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -1.22 -1.50 -1.90 -5.68 -7.56
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -1.22M -1.50M -1.90M -5.68M -7.56M
EBIT 182.40K -68.60K -447.90K -2.35M -4.01M
EBITDA 956.70K 704.90K 287.80K -1.68M -3.32M
EPS Basic -0.01 -0.02 -0.02 -0.08 -0.10
Normalized Basic EPS -0.01 -0.01 -0.01 -0.03 -0.05
EPS Diluted -0.01 -0.02 -0.02 -0.08 -0.10
Normalized Diluted EPS -0.01 -0.01 -0.01 -0.03 -0.05
Average Basic Shares Outstanding 387.99M 355.34M 332.00M 317.45M 306.85M
Average Diluted Shares Outstanding 388.30M 355.46M 332.00M 317.45M 306.85M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings